| 名稱 | B2M-associated HLA-G/aAPC Cell |
| 型號(hào) | CBP74189 |
| 報(bào)價(jià) |  |
| 特點(diǎn) | B2M-associated HLA-G/aAPC Cell |
產(chǎn)品搜索
相關(guān)文章
- 【靶點(diǎn)模型+診斷質(zhì)控】c-Kit常見(jiàn)突變的藥物開(kāi)發(fā)和診斷
- 腫瘤細(xì)胞培養(yǎng)實(shí)驗(yàn)的主要用途
- 【新品上線】AXL篩選模型
- Nectin-4, ADC賽道新星靶點(diǎn)
- Cell Metab：雙信號(hào)通路失調(diào)協(xié)同促進(jìn)肺癌形成
- 細(xì)胞株開(kāi)發(fā)的主要過(guò)程要知道
- 2017腫瘤研究的方向是什么？
- 4-1BB（CD137）靶點(diǎn)藥物篩選模型
- 你知道ATCC細(xì)胞如何解凍嗎？
- EGFR 20外顯子突變類型標(biāo)準(zhǔn)品
聯(lián)系我們
聯(lián)系人：蔣經(jīng)理
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > 腫瘤免疫細(xì)胞株 > CBP74189B2M-associated HLA-G/aAPC Cell
- 詳細(xì)內(nèi)容
| CBP74189 | |
| I. Background | |
| N/A | |
| II. Introduction | |
| Host Cell: | N/A |
| Stability: | 32 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
| Freeze Medium: | 90% FBS+10% DMSO |
| Culture Medium: | F12K+10%FBS+600ug/ml Hygromycin B+3ug/ml puromycin |
| Mycoplasma Testing: | Negative |
| Storage: | Liquid nitrogen |
| Application(s): | Functional(Report Gene) Assay |
| III. Representative Data | |
Figure 1. Recombinant B2M-associated HLA-G/aAPC Cell stably expressing B2M.
Figure 2. Recombinant B2M-associated HLA-G/aAPC Cell stably expressing HLA-G.
Figure 3. Dose Response of LILRB1 Blocking Antibody in LILRB1 Effector Reporter Cells (C13) With B2M-associated HLA-G/aAPC Cells (C15).
Figure 4.Dose Response of LILRB2 Blocking Antibody in LILRB2 Effector Reporter Cells (C24) With B2M-associated HLA-G/aAPC Cells(C15). | |
會(huì)員_a.png)